Inherited HSD3B1 polymorphisms and hormonal therapy resistance

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)1347-1349
Number of pages3
JournalThe Lancet Oncology
Volume17
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Inherited HSD3B1 polymorphisms and hormonal therapy resistance. / Antonarakis, Emmanuel.

In: The Lancet Oncology, Vol. 17, No. 10, 01.10.2016, p. 1347-1349.

Research output: Contribution to journalComment/debate

@article{5ad5c26b9a754e53a8df2623348e69af,
title = "Inherited HSD3B1 polymorphisms and hormonal therapy resistance",
author = "Emmanuel Antonarakis",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/S1470-2045(16)30437-5",
language = "English (US)",
volume = "17",
pages = "1347--1349",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "10",

}

TY - JOUR

T1 - Inherited HSD3B1 polymorphisms and hormonal therapy resistance

AU - Antonarakis, Emmanuel

PY - 2016/10/1

Y1 - 2016/10/1

UR - http://www.scopus.com/inward/record.url?scp=84992392010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992392010&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(16)30437-5

DO - 10.1016/S1470-2045(16)30437-5

M3 - Comment/debate

VL - 17

SP - 1347

EP - 1349

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 10

ER -